SADIE MCDANIEL: Open Payments
NPI 1669915732 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 40 payments from 13 companies in 2025. Trend: 2023 $552 · 2024 $492 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $153 |
| Novartis Pharmaceuticals Corporation | 6 | $130 |
| ABBVIE INC. | 5 | $91 |
| Galderma Laboratories, L.P. | 3 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $50 |
| Amgen Inc. | 2 | $37 |
| Botanix SB Inc | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| PFIZER INC. | 2 | $30 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
Products named: TALTZ, SKYRIZI, NEMLUVIO, COSENTYX, Rhapsido, ILUMYA, OTEZLA, SOFDRA.
Industry payments across NE — which companies pay providers there.
